Study of Tolerant Kidney Transplant Recipients
- Conditions
- Renal TransplantationTransplant RejectionRenal TransplantTransplant ToleranceKidney Transplantation
- First Posted Date
- 2011-04-20
- Last Posted Date
- 2016-09-30
- Target Recruit Count
- 197
- Registration Number
- NCT01338779
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸NIH Clinical Center, Bethesda, Maryland, United States
🇺🇸Swedish Medical Center, Seattle, Washington, United States
Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3
- Conditions
- Shigella Infection
- Interventions
- Other: PlaceboBiological: WRSs2Biological: WRSs3
- First Posted Date
- 2011-04-18
- Last Posted Date
- 2019-01-28
- Target Recruit Count
- 89
- Registration Number
- NCT01336699
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati, Ohio, United States
Long-Term Effects of Sublingual Grass Therapy
- Conditions
- Rhinitis, Allergic, Seasonal
- Interventions
- Biological: Sublingual immunotherapy (SLIT)Other: PlaceboBiological: Subcutaneous immunotherapy (SCIT)
- First Posted Date
- 2011-04-14
- Last Posted Date
- 2017-06-02
- Target Recruit Count
- 106
- Registration Number
- NCT01335139
- Locations
- 🇬🇧
Royal Brompton Hospital, London, United Kingdom
Eosinophilic Esophagitis Databank
- Conditions
- EsophagitisEosinophilic Esophagitis
- First Posted Date
- 2011-03-28
- Last Posted Date
- 2017-08-28
- Target Recruit Count
- 709
- Registration Number
- NCT01323803
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸National Jewish Health, Denver, Colorado, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in Mali
- Conditions
- Malaria
- First Posted Date
- 2011-03-24
- Last Posted Date
- 2022-03-31
- Target Recruit Count
- 1188
- Registration Number
- NCT01322581
- Locations
- 🇲🇱
University of Bamako, Faculty of Medicine, Pharmacy and Odontostomatology, Bamako, Mali
Research Study of ATG and Rituximab in Renal Transplantation
- Conditions
- Renal Transplant Recipients
- Interventions
- First Posted Date
- 2011-03-21
- Last Posted Date
- 2018-11-29
- Target Recruit Count
- 10
- Registration Number
- NCT01318915
- Locations
- 🇺🇸
University of California San Francisco Medical Center, San Francisco, California, United States
🇺🇸University of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸Rogosin Institute/New York Presbyterian-Cornell, New York, New York, United States
H5N1 Mix and Match With MF59
- Conditions
- Influenza
- Interventions
- First Posted Date
- 2011-03-17
- Last Posted Date
- 2013-01-25
- Target Recruit Count
- 270
- Registration Number
- NCT01317745
- Locations
- 🇺🇸
University of Iowa - Infectious Disease Clinic, Iowa City, Iowa, United States
🇺🇸Emory Children's Center - Division of Pediatric Infectious Diseases, Atlanta, Georgia, United States
🇺🇸Emory Vaccine Center - The Hope Clinic, Decatur, Georgia, United States
H5N1 Mix and Match With AS03
- Conditions
- Influenza
- Interventions
- Other: Phosphate Buffered Saline (PBS) diluentDrug: AS03 AdjuvantBiological: Sanofi H5N1 Antigen
- First Posted Date
- 2011-03-17
- Last Posted Date
- 2013-01-18
- Target Recruit Count
- 245
- Registration Number
- NCT01317758
- Locations
- 🇺🇸
Group Health Research Institute - Seattle, Seattle, Washington, United States
🇺🇸University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore, Maryland, United States
🇺🇸Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States
Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults
- First Posted Date
- 2011-03-15
- Last Posted Date
- 2019-02-05
- Target Recruit Count
- 716
- Registration Number
- NCT01314911
- Locations
- 🇺🇸
East Valley Family Physicians, Chandler, Arizona, United States
🇺🇸Horizon Research Group of Opelousas, LLC, Eunice, Louisiana, United States
🇺🇸Michael Seep, MD; Centex Studies, Lake Charles, Louisiana, United States
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
- Conditions
- Diabetes Mellitus, Type 1
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸Washington University, St. Louis, Missouri, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States